The Breast International Group (BIG) 1-98 study evaluated adjuvant endocrine therapy in postmenopausal women who had hormone receptor-positive early-stage breast cancer. The study participants were ...
Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...
Metastatic breast cancer subtypes and biomarkers are crucial for guiding treatment decisions and managing disease progression. ER-positive, HER2-negative breast cancer treatment often begins with ...
EPT use is associated with increased risk of luminal-like breast cancer subtypes, especially in women with a healthy weight. ET use shows a lower occurrence of certain breast cancer subtypes in women ...
NEW YORK — Research from Weill Cornell Medicine has identified a molecular pathway linking omega-6 linoleic acid—a common dietary fat in Western diets—to the growth of triple-negative breast cancer.
To achieve approval for use in clinical practice, new drugs in development must demonstrate exceptional anti-tumor activity together with acceptable tolerability and demonstrate superiority over the ...
Hosted on MSN
Why Many Doctors Now Believe Metastatic Breast Cancer Should Be Treated as a Manageable Chronic Condition
For decades, a diagnosis of metastatic breast cancer-the stage when cancer spreads beyond the breast to distant parts of the body-was often accompanied by a grim prognosis. Survival was measured in ...
The study focused on two particularly hard-to-treat breast cancer subtypes: triple-negative breast cancer and HER2-enriched breast cancer. Both forms are known for their resistance to conventional ...
Seven scientists with the Fred Hutch Cancer Center/University of Washington/Seattle Children’s Cancer Consortium received another year of funding from the Breast Cancer Research Foundation, or BCRF, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback